Every M&A revenue-synergy case assumes a unified go-to-market motion the day after close. In practice, legacy sales reps, newly-acquired specialized teams, and channel partners are often still calling on the same global accounts with different pricing, different messaging, and no shared account plan — and the synergy case quietly erodes.
The commercial question every acquirer eventually asks: who actually owns this account now, and how do we get three sales organizations pulling toward one number?
"Commercial synergies call for product, pricing, and sales teams working in lockstep."
McKinsey's M&A practice is explicit that revenue synergies — unlike cost synergies, which can be captured with a spreadsheet exercise — depend on cross-functional coordination across the exact seams where deals break down: legacy versus acquired sales forces, direct versus channel coverage, and pricing that was never built to be reconciled.
Their research also points to the fix: a dedicated integration management office with named owners and measurable KPIs for each synergy lever, rather than leaving commercial integration to "figure itself out" after close. The deals that hit their revenue synergy targets are the ones that treated the sales org redesign as seriously as the deal itself.
The specific brands and territories change deal to deal — the structural collision between legacy, specialized, and channel coverage on the same enterprise account doesn't.
A generalized post-merger commercial integration pattern — not tied to any specific deal, account, or organization.
The deal thesis is sound. The failure mode is almost always structural, not strategic.
Legacy and acquired reps calling on the same buyer with no coordination, eroding trust before the synergy story is even told.
No named owner for the combined relationship means every escalation becomes a turf negotiation instead of a customer conversation.
Different pricing, different value props, sometimes in the same week — the customer notices before leadership does.
Without one plan and one set of KPIs, cross-sell targets stay aspirational instead of becoming quota.
The org charts differ; the fix is the same set of decisions, made early and made explicit.
Two sales organizations, two CRMs, two comp plans, one set of global accounts — and a synergy target on the board deck that assumes it already works.
Commercial angle: a named integration owner and a reconciled account plan convert a synergy assumption into a trackable KPI within the first two quarters.
Large pharma accounts spanning multiple product lines and business units, each with its own rep and its own view of the relationship.
Commercial angle: a single strategic account framework surfaces cross-BU opportunity that no individual rep can see alone.
Newly acquired channel relationships colliding with existing direct coverage on the same named accounts — a common step-out-deal byproduct.
Commercial angle: clear rules of engagement protect channel margin and direct relationships simultaneously, instead of forcing a zero-sum fight.
The combined portfolio has genuine cross-sell logic on paper — but the reps who'd need to pitch it have never been trained on, or compensated for, the other company's product line.
Commercial angle: enablement and comp plan redesign turn a synergy slide into pipeline within the first sales cycle post-close.
A commercial framework for diagnosing where legacy, specialized, and channel coverage collide on your most important accounts — built on managing a multi-account, multi-stakeholder revenue base through a major industry integration.